Immunogenicity of a Candidate Live Attenuated Vaccine for Rift Valley Fever Virus with a Two-Segmented Genome. (2023)

First Author: Ayers VB
Attributed to:  US-UK BBSRC-NIFA Collab: Control of emerging bunyaviruses funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/vim.2022.0104

PubMed Identifier: 36399689

Publication URI: http://europepmc.org/abstract/MED/36399689

Type: Journal Article/Review

Volume: 36

Parent Publication: Viral immunology

Issue: 1

ISSN: 0882-8245